Drugs / MDX-1401
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00634452 | Feb 2008 → Jan 2010 | Hodgkins lymphoma | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDX-1401 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00634452 ↗ |
| Route | Intravenous | “IV weekly for 4 weeks” NCT00634452 ↗ |